Via Specialty Pharmacy Continuum
According to specialty pharmacy experts, patients who rely on specialty drugs to treat their rare and complex conditions may be forced to pay a large percentage of the drug’s cost instead of a traditional fixed copay, if they are in an Affordable Care Act (ACA) exchange health plan.
Despite some of the exchange plans having the draw of lower monthly premiums, people should prepare themselves for higher deductibles and unpredictable out of pocket costs. Even though the cost structures do vary between the exchange plans, patients may face this issue no matter what exchange plan they are enrolled in.
Avalere examined 603 unique plan designs offered by 60 different carriers in 19 states to assess whether specialty medications are being put in a higher tier with a larger percentage of coinsurance, said Jenna Stento, a senior manager at Avalere. The analysis found that 59% of silver plans on exchanges across the country use coinsurance on the specialty tier instead of a fixed copay. It also found that 23% of silver plans charged coinsurance rates of at least 30% more than the cost of the drugs on the highest formulary tier, and 60% of lower-premium bronze plans apply specialty tier coinsurance greater than 30% of the drug price.
“This examination highlights the fact that patients relying on specialty medications are going to have to lay down significant finances up front until they hit the out-of-pocket cap, which is $6,350 for most people and $2,250 if that person is 200% below the federal poverty rate,” said Ms. Stento. “The fact that patients will be paying an unknown percentage will make it harder for some to plan financially, and will raise questions about access and availability.”
With the number of underinsured and strained patients continuously growing, how can these concerns be corrected?
_________________________________________________________________
To learn more about Specialty Pharmacies, Specialty Drugs, the Affordable Care Act, and much more, join us in Boston this September for the Specialty Pharmacy Collaboration Summit.
Register by 7/25 with the code XP1968BLOG and take an extra $100 off the current rate - that is $500 in total savings! Register here.
See you in Boston!
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.
Subscribe
Blog Archive
-
▼
2014
(135)
-
▼
July
(17)
- How to Address Commercial Ops, Commercial Contract...
- Complimentary Webinar | Moving and Improving: Usin...
- MDRP Lifetime Achievement Award
- Is Medicaid Expansion Feasible?
- How Can We Sustain the Innovation of Biopharmaceut...
- Attention All Health Plans | Buy One, Get One Free...
- 340B Entities: Best Practices for Pricing and Comp...
- 360 Perspective from BCBS, Boston Medical Center, ...
- Best Collaborative Practices for Resolving or Avoi...
- What is the Future of Specialty Pharmacy?
- Obamacare May Raise Patient Costs for Specialty Drugs
- Six Cases Where Big Data Can Reduce Healthcare Costs
- Medicaid Expansion and Healthcare Exchanges
- Rising Healthcare Costs | What are the Biggest Cha...
- The 5 Biggest Challenges for Stakeholders in the O...
- What are the biggest pain points that GP Professio...
- Moving and Improving: Using Data and Informatics t...
-
▼
July
(17)
No comments:
Post a Comment